UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006972
Receipt number R000008114
Scientific Title Effect of branched-chain amino acid-enriched beverage "Amino-Value [CONC.]" supplementation in patients with glucocorticoid-induced muscle atrophy
Date of disclosure of the study information 2011/12/29
Last modified on 2011/12/28 12:54:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of branched-chain amino acid-enriched beverage "Amino-Value [CONC.]" supplementation in patients with glucocorticoid-induced muscle atrophy

Acronym

Effect of branched-chain amino acid supplementation in patients with glucocorticoid-induced muscle atrophy

Scientific Title

Effect of branched-chain amino acid-enriched beverage "Amino-Value [CONC.]" supplementation in patients with glucocorticoid-induced muscle atrophy

Scientific Title:Acronym

Effect of branched-chain amino acid supplementation in patients with glucocorticoid-induced muscle atrophy

Region

Japan


Condition

Condition

Rheumatic diseases

Classification by specialty

Medicine in general Endocrinology and Metabolism Neurology
Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To test the effect of commercially available drink "Amino value conc" in patients with rheumatic diseases taking glucocorticoids. To explore the diagnostic and evaluation procedures for skeletal muscle atrophy in those patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase I,II


Assessment

Primary outcomes

Evaluation of muscle mass and function using manual muscle test, bioimpedance, X-ray CT, and MRI imaging.

Key secondary outcomes

Performance Status, evaluation of daily living activity,squatting

Blood and urine biochemistry


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Aminovalue conc 2 bottles after each meal, everyday, for 3 months

Interventions/Control_2

Control

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patints who visit IMSUT Hospital
2. Patients who give a written informed consent
3. At the time of informed consent, patients take and will take prednisolone (>10mg/day) for at least consecutive 3 months.

Key exclusion criteria

Severe kidney dysfunction
Severe proteinuria
Severe diabetes
Hematopoietic disorders
Severe hepatic dysfunction
Congenital abnormality in amino acid metabolism
Severe heart diseases
Patients with artificial ventilation
patients with severe infection
patients who are recruited or was recruited (within 1 month) in other clinical trials
Pregnancy, breast-feeding

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hirotoshi Tanaka

Organization

IMSUT Hospital, Institute of Medical Science, University of Tokyo

Division name

Department of Allergy and Rheumatology

Zip code


Address

4-6-1, Shirokanedai, Minato-ku, Tokyo

TEL

+81-3443-8111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Noritada Yoshikawa

Organization

IMSUT Hospital, Institute of Medical Science, University of Tokyo

Division name

Department of Allergy and Rheumatology

Zip code


Address

4-6-1, Shirokanedai, Minato-ku, Tokyo

TEL

+81-3443-8111

Homepage URL


Email

hirotnk@ims.u-tokyo.ac.jp


Sponsor or person

Institute

IMSUT Hospital, Institute of Medical Science, University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京大学医科学研究所附属病院(東京都)


Other administrative information

Date of disclosure of the study information

2011 Year 12 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2011 Year 08 Month 15 Day

Date of IRB


Anticipated trial start date

2011 Year 12 Month 01 Day

Last follow-up date

2012 Year 12 Month 01 Day

Date of closure to data entry

2012 Year 12 Month 01 Day

Date trial data considered complete

2013 Year 08 Month 01 Day

Date analysis concluded

2013 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2011 Year 12 Month 28 Day

Last modified on

2011 Year 12 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008114


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name